Search clinical trials for: Machine learning algorithm

Total 10000 results

GlaxoSmithKline

Completed

Study of Immunogenicity & Safety of 2 Different Formulations of Human Rotavirus (HRV) Vaccine for the Prophylaxis of Rotavirus Gastroenteritis

Infections, Rotavirus

Finland
GlaxoSmithKline

Completed

Immunogenicity & Safety Study of a Meningococcal Serogroup B Vaccine Given in a 3 Dose Schedule to Healthy Adolescents Aged 12-18 Yrs

Infections, Meningococcal
Ironwood Pharmaceuticals, Inc.

Completed

Ph2a Study to Evaluate IW-3718 in Patients With Gastroesophageal Reflux Not Completely Responsive to Proton Pump Inhibitors

Gastroesophageal Reflux

United States
Fuda Cancer Hospital, Guangzhou
University of Michigan

Completed

Vaccine Therapy in Treating Lung Cancer Patients With Cancer Stem Cells

Neoplasms, Lung

China
Pfizer

Completed

Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 1 to 6 Years.

Tick-borne Encephalitis

Austria, Germany
Pfizer

Completed

Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 6 to 16 Years.

Tick-borne Encephalitis

Germany
Mahidol University
World Health Organization; The Government Pharmaceutical Organization

Completed

Evaluation of Priming Effects by PLAI Vaccine on the Subsequent Response to Inactivated H5N1 Vaccine

Avian Influenza

Thailand
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC

Completed

Preparedness Study - HPV Vaccine

Sexual Transmission of Infection

United States, South Africa
MedImmune LLC
AstraZeneca

Completed

Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults

Healthy | Influenza

United States
PT Bio Farma

Completed

Safety of Hib Vaccine (Bio Farma)

Healthy

Indonesia
National Institute of Allergy and Infectious Diseases...

Completed

A/H5N1in Adult - Aventis

Influenza

United States
Novavax

Completed

Safety, Reactogenicity and Immunogenicity of an H5N1 VLP

Pandemic Influenza

United States
NanoPass Technologies Ltd

Completed

A Pilot Study to Evaluate the Safety and Immunogenicity of Low Dose Flu Vaccines (NANOVAX)

Influenza, Human
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Vaccine Therapy Plus QS21 in Treating Women With Breast Cancer Who Have No Evidence of Disease

Breast Cancer

United States
NovaDigm Therapeutics, Inc.
United States Department of Defense; Cetero Research, San Antonio

Completed

Safety and Immunogenicity Study of a Recombinant Protein Vaccine (NDV-3) Against S.Aureus and Candida

Candidiasis | Staphylococcal Infections

United States
London School of Hygiene and Tropical Medicine
National Institute for Medical Research, Tanzania; Ocean Road Cancer Institute... and other collaborators

Completed

Delivery, Uptake and Acceptability of HPV Vaccination in Tanzanian Girls

Cervical Cancer

Tanzania
NasVax Ltd

Completed

Safety and Immunogenicity Study of Intramuscular CCS/C-adjuvanted Influenza Vaccine in Elderly

Influenza

Israel
International Centre for Diarrhoeal Disease Research...
PATH

Completed

Introduction of an Oral Live Human Rotavirus (Rotarix) Vaccine in Matlab

Rotavirus Gastroenteritis

Bangladesh
Hadassah Medical Organization

Withdrawn

Allogeneic Tumor Cell Vaccination in Patients With Chronic Myeloid Leukemia

Chronic Myeloid Leukemia

Israel
GlycoVaxyn AG

Completed

Safety and Reactogenicity of Bioconjugate Vaccine to Prevent Shigella

Shigellosis

Switzerland
British Columbia Centre for Disease Control

Unknown

TIV Infant/Toddler Response Evaluation (TITRE)- Follow-up & Focus on Influenza B (TITRE II)

Influenza

Canada
Universitaire Ziekenhuizen KU Leuven

Completed

Influenza Vaccination in Hemodialysis Patients and Renal Transplant Recipients

Hemodialysis | Renal Transplantation

Belgium
University Health Network, Toronto

Completed

Improving the Humoral Response to Influenza Vaccine in Lung Transplant Recipients by an Intradermal Strategy

Lung Transplantation | Influenza Vaccines

Canada
Novartis
Novartis Vaccines

Completed

Evaluation of Long-Term Immunogenicity in Subjects Boosted With a TBE Vaccine for Adults

Encephalitis, Tick-Borne

Germany
Novartis
Novartis Vaccines

Completed

Immunogenicity, Safety and Tolerability, of Chiron Meningococcal C Conjugate Vaccine Administered to Healthy Premature and Non Premature Children of 3 Months of Age

Prevention of Meningococcal Infection

Italy
International Vaccine Institute
Göteborg University; National Institute of Hygiene and Epidemiology, Vietnam

Completed

Safety and Immunogenicity of a New Formulation of a Bivalent Killed, Whole-Cell Oral Cholera Vaccine

Cholera

Vietnam
Solvay Pharmaceuticals

Completed

Non-Inferiority Study Comparing the Subunit Vaccines Influvac and Agrippal in China

Healthy

China
Chiron Corporation

Completed

A Phase I, Observer-Blind, Placebo-Controlled Study of the Chiron Vaccine HIV p24/MF59 Administered to Healthy HIV-Seronegative Adults

HIV Infections | HIV Seronegativity

United States
Butantan Institute
Butantan Foundation

Recruiting

Safety and Immunogenicity of the Monovalent Influenza Vaccine A (H5N8) (Inactivated, Fragmented and Adjuvanted) in Adults and Older Adults

Avian Influenza A Virus

Brazil
National Institute of Allergy and Infectious Diseases...

Completed

A Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of MVA-BN Yellow Fever Vaccine With and Without Montanide ISA-720 Adjuvant in 18-45 Year Old Healthy Volunteers

Yellow Fever | Yellow Fever Immunisation

United States
Region Skane

Completed

Combined Pneumococcal Conjugate and Polysaccharide Vaccination in Inflammatory Rheumatic Disease (IPS-BOOSTER)

Rheumatoid Arthritis | Systemic Vasculitis | Spondyloarthritis | Systemic Lupus | Sjögren Syndrome
PATH
University College, London; FHI 360; Medical Research Council Unit, The Gambia; Serum Institute of India Pvt. Ltd...

Completed

Study of 10-valent Pneumococcal Conjugate Vaccine (Pneumosil) Administered in a 2+1 Schedule to Healthy Infants

Pneumonia, Pneumococcal

Gambia
Livzon Pharmaceutical Group Inc.

Active, not recruiting

The Immunogenicity and Safety of V-01-351/V-01D Bivalence Vaccine (Omicron)

COVID-19 Pandemic

China
M.D. Anderson Cancer Center
Celgene Corporation

Terminated

Lenalidomide as Immune Adjuvant in Patient's With Chronic Lymphocytic Leukemia (CLL)

Hematologic Disorder

United States
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Comparison of Immune Responses to Influenza Vaccine In Adults of Different Ages (SLVP015 2007-2017)

Influenza

United States
International Vaccine Institute
Massachusetts General Hospital; EuBiologics Co.,Ltd

Completed

Dose Escalation Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Healthy Adults

Cholera Vaccination Reaction

Korea, Republic of
ModernaTX, Inc.

Completed

A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥50 Years of Age (RSVictory)

Respiratory Syncytial Virus

United States
Columbia University
Merck Sharp & Dohme LLC; Jhpiego

Completed

HPV Vaccination in HIV Infected and HIV Uninfected Adolescents in Eswatini

Hiv | HPV Infection | HPV Vaccine

Eswatini
Steven E Arnold, MD

Completed

A Trial to Evaluate the Effects of BCG in Adults With MCI and Mild-to-Moderate AD

Alzheimer Disease | Mild Cognitive Impairment | Mild Dementia | Moderate Dementia

United States
Texas A&M University
M.D. Anderson Cancer Center; Baylor College of Medicine; Cedars-Sinai Medical... and other collaborators

Completed

BCG Vaccine for Health Care Workers as Defense Against COVID 19 (BADAS)

Coronavirus Infection | Coronavirus | Coronavirus as the Cause of Diseases Classified Elsewhere

United States
GlaxoSmithKline

Completed

A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone or Co-administered With an Adjuvanted Vaccine Against Influenza in Adults Aged 65 Years and Above

Respiratory Syncytial Virus Infections

France, Finland, Belgium, Spain, United Kingdom
National Institute of Allergy and Infectious Diseases...
National Heart, Lung, and Blood Institute (NHLBI); University of Copenhagen; US... and other collaborators

Completed

Vaccination for Recovered Inpatients With COVID-19 (VATICO)

Covid19

United States, Spain, Uganda, Nigeria, Singapore, Switzerland
Benha University
New Jeddah Clinic Hospital

Completed

Accelerated Vaccination Schedule Against Hepatitis B Virus With Combined Hepatitis A and B Vaccine Among Hemodialysis Patients

Hepatitis B | Hemodialysis Complication
Seqirus

Completed

Flucelvax (TIVc or QIVc) Pregnancy Registry

Pregnancy | Influenza, Human | Birth Defect

United States
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of a Multi-Dose Quadrivalent Influenza Vaccine

Influenza

Mexico
National Institute of Allergy and Infectious Diseases...
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Safety of and Immune Response to Two Influenza Vaccines in HIV Infected Children and Adolescents

HIV Infections | Influenza

United States, Puerto Rico
National Institute of Allergy and Infectious Diseases...
HIV Vaccine Trials Network

Completed

Safety and Immune Response to Preventive HIV Immunization With Adenovirus Serotype 5 or 35 Vector

HIV Infections

United States
MedImmune LLC

Completed

A Phase 2 Study to Evaluate Immune Responses of FluMist®

Influenza Vaccine

United States
Novartis Vaccines

Completed

Humoral and Cell Mediated Immunity and Safety of MF59C.1-adjuvanted Subunit Influenza Vaccine or a Conventional Subunit Influenza Vaccine in Previously Unvaccinated Healthy Subjects

Influenza | Seasonal Influenza | Human Influenza | Influenza Due to Unspecified Influenza Virus

Belgium
Nova Immunotherapeutics Limited
The Emmes Company, LLC; Nova Laboratories Limited; Mercia Pharma Inc.

Unknown

The Safety, Tolerance, and Immunogenicity of MAS-1-Adjuvanted Seasonal Inactivated Influenza Vaccine (MER4101) (MER4101)

Influenza, Human

United States

Search clinical trials for: Machine learning algorithm

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Djibouti

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations